Found 3 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Cathepsin K
(Homo sapiens (Human)) | BDBM93169
(Cathepsin Inhibitor, Column 1 Row 2)Show SMILES CC(NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)CNC(=O)Cc1cccc(c1)-c1ccccn1 |r| Show InChI InChI=1S/C28H30N4O4/c1-19(31-28(36)25(32-20(2)33)16-21-9-4-3-5-10-21)26(34)18-30-27(35)17-22-11-8-12-23(15-22)24-13-6-7-14-29-24/h3-15,19,25H,16-18H2,1-2H3,(H,30,35)(H,31,36)(H,32,33)/t19?,25-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | 5.5 | n/a |
SmithKline Beecham Pharmaceuticals
| Assay Description Inhibitors were assayed against human liver Cathepsin L and B. Inhibitors were also evaluated for inhibition against purified recombinant Cathepsin ... |
J Comb Chem 1: 207-15 (1999)
Article DOI: 10.1021/cc9800374 BindingDB Entry DOI: 10.7270/Q2HQ3XHJ |
More data for this Ligand-Target Pair | |
Cathepsin B
(Homo sapiens (Human)) | BDBM93169
(Cathepsin Inhibitor, Column 1 Row 2)Show SMILES CC(NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)CNC(=O)Cc1cccc(c1)-c1ccccn1 |r| Show InChI InChI=1S/C28H30N4O4/c1-19(31-28(36)25(32-20(2)33)16-21-9-4-3-5-10-21)26(34)18-30-27(35)17-22-11-8-12-23(15-22)24-13-6-7-14-29-24/h3-15,19,25H,16-18H2,1-2H3,(H,30,35)(H,31,36)(H,32,33)/t19?,25-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | 5.5 | n/a |
SmithKline Beecham Pharmaceuticals
| Assay Description Inhibitors were assayed against human liver Cathepsin L and B. Inhibitors were also evaluated for inhibition against purified recombinant Cathepsin ... |
J Comb Chem 1: 207-15 (1999)
Article DOI: 10.1021/cc9800374 BindingDB Entry DOI: 10.7270/Q2HQ3XHJ |
More data for this Ligand-Target Pair | |
Cathepsin L
(Homo sapiens (Human)) | BDBM93169
(Cathepsin Inhibitor, Column 1 Row 2)Show SMILES CC(NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)CNC(=O)Cc1cccc(c1)-c1ccccn1 |r| Show InChI InChI=1S/C28H30N4O4/c1-19(31-28(36)25(32-20(2)33)16-21-9-4-3-5-10-21)26(34)18-30-27(35)17-22-11-8-12-23(15-22)24-13-6-7-14-29-24/h3-15,19,25H,16-18H2,1-2H3,(H,30,35)(H,31,36)(H,32,33)/t19?,25-/m0/s1 | PDB MMDB
UniProtKB/TrEMBL
B.MOAD GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | 5.5 | n/a |
SmithKline Beecham Pharmaceuticals
| Assay Description Inhibitors were assayed against human liver Cathepsin L and B. Inhibitors were also evaluated for inhibition against purified recombinant Cathepsin ... |
J Comb Chem 1: 207-15 (1999)
Article DOI: 10.1021/cc9800374 BindingDB Entry DOI: 10.7270/Q2HQ3XHJ |
More data for this Ligand-Target Pair | |